Articles dans des revues avec comité de lecture (260)
  1. 190. Monory, K., Tzavara, E. T., Lexime, J., Ledent, C., Parmentier, M., Borsodi, A., & Hanoune, J. (2002). Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochemical and biophysical research communications, 292(1), 231-235. doi:10.1006/bbrc.2002.6635
  2. 191. Brooks, J. W., Pryce, G., Bisogno, T., Jaggar, S. I., Hankey, D. J. R., Brown, P., Bridges, D., Ledent, C., Bifulco, M., Rice, A. S. C., Di Marzo, V., & Baker, D. (2002). Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. European journal of pharmacology, 439(1-3), 83-92.
  3. 192. Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002). Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacologia, 159(4), 379-387. doi:10.1007/s00213-001-0946-5
  4. 193. Morrison, R. R., Talukder, M. A. H., Ledent, C., & Mustafa, S. J. (2002). Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors. American journal of physiology. Heart and circulatory physiology, 282(2), H437-H444. doi:10.1152/ajpheart.00723.2001
  5. 194. Varma, N., Carlson, G. C., Ledent, C., & Alger, B. E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. The Journal of neuroscience, 21(24), RC188.
  6. 195. Katona, I., Rancz, E. A., Acsady, L., Ledent, C., Mackie, K., Hajos, N., & Freund, T. F. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. The Journal of neuroscience, 21(23), 9506-9518.
  7. 196. Dassesse, D., Ledent, C., Parmentier, M., & Schiffmann, S. N. (2001). Acute and chronic caffeine administration differentially alters striatal gene expression in wild-type and adenosine A(2A) receptor-deficient mice. Synapse, 42(2), 63-76. doi:10.1002/syn.1100
  8. 197. El Yacoubi, M., Ledent, C., Parmentier, M., Ongini, E., Costentin, J., & Vaugeois, J.-M. (2001). In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261. European journal of neuroscience, 14(9), 1567-1570. doi:10.1046/j.0953-816x.2001.01771.x
  9. 198. Derkinderen, P., Toutant, M., Kadaré, G., Ledent, C., Parmentier, M., & Girault, J.-A. (2001). Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. The Journal of biological chemistry, 276(41), 38289-38296. doi:10.1074/jbc.M105630200
  10. 199. El Yacoubi, M., Ledent, C., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J., & Vaugeois, J.-M. (2001). Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. British Journal of Pharmacology, 134(1), 68-77. doi:10.1038/sj.bjp.0704240
  11. 200. Dassesse, D., Massie, A., Ferrari, R., Ledent, C., Parmentier, M., Arckens, L., Zoli, M., & Schiffmann, S. N. (2001). Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors. Journal of neurochemistry, 78(1), 183-198. doi:10.1046/j.1471-4159.2001.00389.x
  12. 201. Wenger, T., Ledent, C., Csernus, V., & Gerendai, I. (2001). The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochemical and biophysical research communications, 284(2), 363-368. doi:10.1006/bbrc.2001.4977
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Suivant >>